Halozyme Therapeutics Inc (HALO)
41.23
+0.37
(+0.91%)
USD |
NASDAQ |
May 07, 16:00
42.47
+1.24
(+3.01%)
After-Hours: 20:00
Halozyme Therapeutics Shares Outstanding: 126.82M for Feb. 12, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| February 12, 2024 | 126.82M |
| December 31, 2023 | 126.77M |
| October 31, 2023 | 132.10M |
| September 30, 2023 | 132.08M |
| July 31, 2023 | 131.92M |
| June 30, 2023 | 131.86M |
| April 28, 2023 | 131.68M |
| March 31, 2023 | 131.66M |
| March 06, 2023 | 135.42M |
| February 14, 2023 | 135.37M |
| December 31, 2022 | 135.15M |
| October 31, 2022 | 135.21M |
| September 30, 2022 | 135.21M |
| August 18, 2022 | 139.29M |
| August 02, 2022 | 137.78M |
| June 30, 2022 | 137.68M |
| May 04, 2022 | 137.95M |
| March 31, 2022 | 137.89M |
| March 07, 2022 | 137.77M |
| February 14, 2022 | 137.70M |
| December 31, 2021 | 137.50M |
| October 25, 2021 | 140.79M |
| September 30, 2021 | 140.97M |
| August 03, 2021 | 142.33M |
| June 30, 2021 | 142.18M |
| Date | Value |
|---|---|
| May 05, 2021 | 142.39M |
| March 31, 2021 | 143.38M |
| March 08, 2021 | 143.30M |
| February 17, 2021 | 135.28M |
| December 31, 2020 | 135.03M |
| October 28, 2020 | 135.18M |
| September 30, 2020 | 135.37M |
| August 05, 2020 | 137.03M |
| June 30, 2020 | 136.67M |
| May 06, 2020 | 135.81M |
| March 31, 2020 | 135.36M |
| March 02, 2020 | 138.07M |
| February 14, 2020 | 138.23M |
| December 31, 2019 | 136.71M |
| November 07, 2019 | 146.54M |
| September 30, 2019 | 146.46M |
| July 31, 2019 | 146.31M |
| June 30, 2019 | 145.86M |
| April 30, 2019 | 145.51M |
| March 31, 2019 | 145.36M |
| March 04, 2019 | 145.30M |
| February 15, 2019 | 145.03M |
| February 14, 2019 | 145.03M |
| December 31, 2018 | 144.72M |
| October 30, 2018 | 144.56M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
126.77M
Minimum
Dec 31 2023
146.54M
Maximum
Nov 07 2019
137.30M
Average
137.03M
Median
Aug 05 2020
Shares Outstanding Benchmarks
| Novavax Inc | 139.95M |
| Globus Medical Inc | 135.37M |
| Denali Therapeutics Inc | 142.54M |
| AIM ImmunoTech Inc | 49.90M |
| Protalix BioTherapeutics Inc | 73.05M |